NZ320932A - Short forms of chemokine b-8 - Google Patents

Short forms of chemokine b-8

Info

Publication number
NZ320932A
NZ320932A NZ320932A NZ32093296A NZ320932A NZ 320932 A NZ320932 A NZ 320932A NZ 320932 A NZ320932 A NZ 320932A NZ 32093296 A NZ32093296 A NZ 32093296A NZ 320932 A NZ320932 A NZ 320932A
Authority
NZ
New Zealand
Prior art keywords
polypeptide
chemokine
short forms
underexpression
diagnosing
Prior art date
Application number
NZ320932A
Inventor
John White
Edward Appelbaum
Daniel O'shannessy
James Allan Fornwald
Kevin O'donnell
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NZ320932A publication Critical patent/NZ320932A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

he present invention relates to an isolated polypeptide of amino acid residues 1 to 82 of SEQ ID NO:1, 2, 4 and the use of the polypeptide for preparing a medicament for protecting bone marrow cells from chemotherapeutic agents. Also claimed is a process for diagnosing a disease related to the underexpression of the polypeptide, a vector, and host cell comprising the polypeptide.
NZ320932A 1995-09-29 1996-09-27 Short forms of chemokine b-8 NZ320932A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US451795P 1995-09-29 1995-09-29
PCT/US1996/015592 WO1997012041A1 (en) 1995-09-29 1996-09-27 SHORT FORMS OF CHEMOKINE β-8

Publications (1)

Publication Number Publication Date
NZ320932A true NZ320932A (en) 2000-01-28

Family

ID=21711157

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ320932A NZ320932A (en) 1995-09-29 1996-09-27 Short forms of chemokine b-8

Country Status (16)

Country Link
EP (1) EP0859842A4 (en)
JP (1) JPH11512610A (en)
KR (2) KR19990063834A (en)
CN (2) CN1198186A (en)
AU (1) AU711573B2 (en)
BG (1) BG102413A (en)
BR (1) BR9610671A (en)
CZ (1) CZ92198A3 (en)
EA (1) EA199800352A1 (en)
HU (1) HUP9802699A3 (en)
NO (1) NO981387L (en)
NZ (1) NZ320932A (en)
PL (1) PL326080A1 (en)
TR (1) TR199800575T1 (en)
WO (1) WO1997012041A1 (en)
ZA (1) ZA968204B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US6623942B2 (en) 1994-03-08 2003-09-23 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polynucleotides
CN1239510A (en) * 1996-09-30 1999-12-22 人类基因组科学公司 Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
KR19990042713A (en) * 1997-11-27 1999-06-15 허일섭 Method for preparing CDNA and recombinant LKN-1 of C 6 beta-chemokine LKN-1 isolated from human
AU2505601A (en) * 1999-11-15 2001-05-30 Wolf-Georg Forssmann Novel use of hcc-2
US20030215460A1 (en) * 2002-05-07 2003-11-20 Schall Thomas J. Methods and compositions for inducing an immune response

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970700438A (en) * 1993-12-22 1997-02-12 로버트 에이치. 벤슨 MACROPHAGE INFLAMMATORY PROTEINS -3, -4 AND -1sg (g)
JPH11505417A (en) * 1995-05-05 1999-05-21 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド Human chemokine beta-8, chemokine beta-1, and macrophage inflammatory protein-4
DE69631253T2 (en) * 1995-10-24 2004-11-18 Human Genome Sciences, Inc. MOBILIZATION OF HEMATOPOIETIC STEM CELLS BY A CHEMOKIN
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10

Also Published As

Publication number Publication date
PL326080A1 (en) 1998-08-17
EP0859842A4 (en) 1999-02-24
EA199800352A1 (en) 1998-12-24
BG102413A (en) 1999-04-30
JPH11512610A (en) 1999-11-02
AU711573B2 (en) 1999-10-14
ZA968204B (en) 1997-04-09
CN1198186A (en) 1998-11-04
CN1405180A (en) 2003-03-26
EP0859842A1 (en) 1998-08-26
NO981387L (en) 1998-05-29
WO1997012041A1 (en) 1997-04-03
HUP9802699A3 (en) 2000-09-28
HUP9802699A2 (en) 1999-03-29
BR9610671A (en) 1999-07-06
KR19990063834A (en) 1999-07-26
MX9802380A (en) 1998-08-30
CZ92198A3 (en) 1998-07-15
AU7379096A (en) 1997-04-17
KR20030096447A (en) 2003-12-31
NO981387D0 (en) 1998-03-26
TR199800575T1 (en) 1998-06-22

Similar Documents

Publication Publication Date Title
HK1088068A1 (en) Diagnostic and therapeutic epitope
AR056723A2 (en) PURIFIED POLYPEPTIDE METHOD TO PRODUCE IT, METHOD TO IDENTIFY IT AND / OR INSULATE IT PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ISOLATED NUCLEIC ACID SEQUENCE CODIFYING SUCH POLYPEPTIDE, VECTOR THAT CONTAINS SUCH DUCTED DUCT DUCTED
EP0861894A4 (en) Differentiation-suppressive polypeptide
CA2263889A1 (en) P-selectin ligand proteins
AUPP051497A0 (en) Antimicrobial peptides
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
NZ332255A (en) Use of herpes simplex virus glycoprotein d variants
GB9722320D0 (en) Human cell cycle checkpoint proteins
CA2147623A1 (en) Novel p-selectin ligand protein
NZ320932A (en) Short forms of chemokine b-8
NZ506748A (en) Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production
CA2260365A1 (en) Differentiation-suppressive polypeptide
EP1037999A4 (en) Porphorymonas gingivalis polypeptides and nucleotides
CA2186423A1 (en) Protein which induces interferon-gamma production by immunocompetent cell
AU3539484A (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
GB8821785D0 (en) Peptide compounds
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
WO1995030001A3 (en) Novel p-selectin ligand protein
SG66214A1 (en) Novel chemotactic factor
NZ334970A (en) Human growth gene and short stature gene region using sequence derived from the SHOX gene
CA2241786A1 (en) Novel amp activated protein kinase
EP1022332A4 (en) Beta-fructofuranosidase and gene thereof
EP0384731A3 (en) Osteogenic growth polypeptides identified from regenerating bone marrow
WO1994025606A3 (en) Recombinant alanine racemase and gapdh from tolypocladium
WO1997008317A3 (en) Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)